Polycystic Ovarian Syndrome Treatment Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030

Published Date : May 2021 | No. of Pages : 250 Pages | Category : Healthcare

The global Polycystic Ovarian Syndrome Treatment market size is expected to be worth around US$ 15.1 billion by 2030, according to a new report by Vision Research Reports.

The global Polycystic Ovarian Syndrome Treatment market size was valued at US$ 13.3  billion in 2020 and is anticipated to grow at a CAGR of 10.0% during forecast period 2021 to 2030.

Growth Factors

 According to the Centers of Disease Control & Prevention (CDC), Polycystic Ovary Syndrome (PCOS) is the most common cause of female infertility. Approximately 6% to 12% women of reproductive age suffer from PCOS in the U. S. Moreover, progression of this condition can lead to metabolic abnormalities, which may result in development of type 2 diabetes, if the syndrome is not treated on time. The severity of the disorder increases the risk of developing uterine and endometrial cancers in patients. Thus, early diagnosis and effective treatment are significant for successful recovery. 

Presently, no specific drug is commercially available for this condition. Thus, treating symptoms is the prime aim of the treatment regimen. Owing to the various symptoms associated with this syndrome, a range of drug class/combinations is used in the treatment. Therefore, market leaders are focusing on developing a specific drug/treatment to cure the root cause of this disease. AstraZeneca is one of the leaders involved in developing such a drug.

Report Highlights

PCOS is a genetic disorder that passes from one generation to another in a family, which leads to a high incidence of this condition across the globe. In addition, sedentary lifestyle and faulty dietary habits are augmenting the prevalence of this condition. As a result, constantly rising patient population is propelling the growth of this market.

Presently, no condition specific treatment is available. As a result, the treatments that are available are symptom specific. Polycystic ovary syndrome therapy mainly includes lifestyle modification that involves a balanced diet, exercise; and drugs such as oral contraceptives, insulin-sensitizing agents, anti-obesity agents, and antidepressants. In cases where patients do not respond effectively to any drug therapy, surgical procedures such as ovarian wedge resection and laparoscopic ovarian drilling are recommended.

Insulin-sensitizing agents are the largest segment. Various products such as Glucophage XR (Metformin) and other products containing Troglitazone, Rosiglitazone, and Pioglitazone are sold widely. In PCOS, metabolic dysfunction may lead to excess androgen secretion, which may affect insulin secretion and may ultimately increase the risk of diabetes. Thus, insulin-sensitizing agents play an important role in the therapeutics as they lower insulin levels and lead to a decrease in production of ovarian androgen as well as balance hormone levels.

Oral Contraceptive Pills (OCPs) segment is expected to be the fastest growing segment. Commercially available oral contraceptive products mainly include Ethinyl Estradiol, Medroxyprogesterone Acetate, and Drospirenone. These OCPs are used for treatment of irregular or absent menstrual cycle, severe menstrual pain, Premenstrual syndrome (PMS), and acne, which are common symptoms of Polycystic ovary syndrome. As a result, demand for OCPs segment is expected to increase at the fastest rate during the forecast period.     

When drug therapy proves to be ineffective, surgery is recommended for treatment. The most common surgeries performed for treatment of PCOS include ovarian wedge resection and laparoscopic drilling of ovaries. Some of the other procedures that are performed are oophorectomy, hysterectomy, and cyst aspiration.

Ovarian wedge resection involves removal of a part of ovary, which may help regulate the menstrual cycle and promote ovulation. Physicians strongly recommend not undergoing wedge resection due the risk of scarring on ovaries. In addition, associated risks, such as pain in lower abdomen, bleeding, scarring on reproductive organs or damage to them, and infection, are making drug therapies a preferred option over surgical procedures for treatment of PCOS.

North America is the most developed market followed by Europe. Rising incidence of obesity and overweight is resulting in an increase in number of people suffering from PCOS, which is one of the key factors contributing to market growth in North America. Moreover, increasing awareness about benefits of regular checkup is leading to an increase in number of new cases being diagnosed each year in this region. 

The U.S. is leading the overall North America market with the largest revenue share. The large population suffering from PCOS in this country is primarily driving growth of this market. Moreover, presence of major market players, such as Merck, Abbott, and BMS, in the U.S. is anticipated to contribute significantly in the revenue generation of the country.

In Asia Pacific, China and India together account for the largest population base. Thus, the presence of a large target patient pool creates significant growth opportunities for PCOS treatment market in the region. Governments of these countries are focusing on controlling the growing prevalence of PCOS by conducting programs that support diagnosis & therapeutics of this syndrome and the required lifestyle modification. These programs are leading to an increase in awareness about PCOS and its associated risks such as the development of insulin resistance, obesity, and in some cases infertility. These factors are expected to drive the Asia Pacific market in the near future.

Key Players

AstraZeneca, Bayer AG, Merck KGaA, Abbott, Sanofi, Pfizer, Inc., Bristol-Myer Squibb Company, and Novartis AG. 

Market Segmentation

  • Drug Class Outlook 

    • Oral Contraceptives

    • Antiandrogens

    • Insulin-sensitizing Agent

    • Antidepressant

    • Anti-obesity

  • Surgery Outlook

    • Ovarian Wedge Resection

    • Laparoscopic Ovarian Drilling

  • Regional Outlook 

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • UK

    • Asia Pacific

      • China

      • Japan

    • Latin America

      • Mexico

      • Brazil

    • MEA

      • South Africa

The Polycystic Ovarian Syndrome Treatment market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report provides size (in terms of volume and value) of Polycystic Ovarian Syndrome Treatment market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global Polycystic Ovarian Syndrome Treatment market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Polycystic Ovarian Syndrome Treatment market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted Polycystic Ovarian Syndrome Treatment market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

In terms of production side, this report researches the Polycystic Ovarian Syndrome Treatment capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.

In terms of consumption side, this report focuses on the consumption of Polycystic Ovarian Syndrome Treatment by regions (countries) and application.

Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Polycystic Ovarian Syndrome Treatment market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Polycystic Ovarian Syndrome Treatment market companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Polycystic Ovarian Syndrome Treatment market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the Polycystic Ovarian Syndrome Treatment industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

The Polycystic Ovarian Syndrome Treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Polycystic Ovarian Syndrome Treatment market.

Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Polycystic Ovarian Syndrome Treatment market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.

Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Polycystic Ovarian Syndrome Treatment market. These factors have benefited the growth of the global market for Polycystic Ovarian Syndrome Treatment. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.

New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Polycystic Ovarian Syndrome Treatment. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).

In this study, the years considered to estimate the market size of Polycystic Ovarian Syndrome Treatment are as follows:

  • Historic Year: 2017-2020
  • Base Year: 2021
  • Forecast Year 2021 to 2030

Reasons to Purchase this Report:

- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Market Size Estimation

Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).

The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.

Secondary Sources

Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.

Primary Sources

 In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

To strategically profile the key players and comprehensively analyze their growth strategies.

Featured Research Reports

  • Featured Research Reports

    Trauma Care Centers Market (By Facility Type: In-house, Standalone; By Trauma Type: Falls, Traffic-related Injuries; By Service Type) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

  • Featured Research Reports

    Monkeypox Vaccine And Treatment Market (By Product: Vaccine, Drugs) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

  • Featured Research Reports

    Hyaluronic Acid Market (By Application: Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

  • Featured Research Reports

    AI in Oncology Market (By Treatment: Chemotherapy, Radiotherapy, Immunotherapy, Targeted Therapy, Gene Therapy; By Cancer Type; By Application) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

  • Featured Research Reports

    Paracetamol IV Market (By Application: Surgical, Non-surgical; By Indication: Pyrexia, Pain; By End-use: Hospitals, Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030